Project Officer, Drug Development Section
Office of Biodefense Research Affairs
Investigators are to communicate only with the NIAID Program Officer. The Project Officer is to be the only direct contact with the contractor.
Investigators must implement a Non-Clinical Evaluation Agreement with the Division of Microbiology and Infectious Diseases (DMID).
Users must also provide abstracts, draft publications, press, and other materials prior to submission to journals, conferences, or other public release of information. Communications should acknowledge the role that access to preclinical services provided by the Therapeutic Development Services program played in furthering the research being reported.
Last Updated March 05, 2014